Latest The Texas Heart Institute Stories
DETROIT, Feb. 15, 2012 /PRNewswire-USNewswire/ -- Few hospitals have as much experience with the Berlin Heart as DMC Children's Hospital of Michigan. This is why the U.S. Food and Drug Administration (FDA) was eager to hear testimony from Henry L. Walters III, MD, chief of cardiovascular surgery at DMC Children's Hospital of Michigan. Dr. Walters provided testimony about the device at a recent public hearing. After reviewing the clinical trial data and hearing testimony from Dr....
LA JOLLA, Calif., Jan. 25, 2012 /PRNewswire/ -- Interest in adult stem cell therapies and their clinical applicability in treating and helping patients is growing, while accurate information remains difficult to access. Cell Society International, a nonprofit organization, is dedicated to advancing the clinical applications of adult stem cell therapies worldwide through education and the collaboration of world thought leaders. According to Emerson C. Perin, MD, PhD, Director,...
SynCardia Profitable for 1st Time in Company’s 10-Year History Tucson, AZ (PRWEB) January 04, 2012 SynCardia Systems, Inc., manufacturer of the world’s only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that in 2011, the company nearly doubled sales for the second straight year, representing a four-fold increase since 2009. “This is the first full year that SynCardia has been profitable during the company’s 10-year history,” said Michael...
TUCSON, Ariz., Jan. 4, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that in 2011, the company nearly doubled sales for the second straight year, representing a four-fold increase since 2009. (Photo: http://photos.prnewswire.com/prnh/20120104/LA29865) "This is the first full year that SynCardia has been profitable during the company's...
The U.S. Food and Drug Administration (FDA) said on Friday that it has approved the first heart pump for children with heart failure, giving a new treatment option for patients who are too small to receive adult implants. The ventricular assist device is made by Germany-based Berlin Heart, and is the first heart pump approved to help children survive as they await a heart transplant. The device does the work of a normal heart in children with congenital or other cardiovascular defects,...
ORLANDO, Florida and MELBOURNE, Australia, November 14, 2011 /PRNewswire/ -- - Revascor(TM), Mesoblast's proprietary Mesenchymal Precursor Cell (MPC) product for cardiovascular diseases, was safe and well-tolerated at all doses, with no clinically relevant immune responses to donor cells - Revascor(TM) therapy significantly reduced cardiac mortality and major adverse cardiac events (MACE) in patients with congestive...
AUSTIN, Texas, Sept. 27, 2011 /PRNewswire/ -- (http://www.myprgenie.com) -- Texans for Stem Cell Research (TSCR), a non-partisan, non-profit 501(c)3 volunteer organization announces the panel of stem cell experts from Texas and around the globe that will convene in Austin at the TSCR Second Annual Educational Symposium with a welcome address by Dr. Kenneth I. Shine, Executive Vice Chancellor for Health Affairs for The University of Texas System. The symposium will be held on Sept. 30th at...
HOUSTON, June 29, 2011 /PRNewswire/ -- Texas Children's Hospital in Houston announced today that it is the first pediatric hospital in the United States to implant an artificial heart into the chest of a 17-year-old patient as the only option to save his life. The history-making patient underwent a rare 15-hour operation on May 22 and is currently recovering at Texas Children's Hospital. He is one of three congenital heart patients in the nation to get such a device. To view a video of the...
Pluromed, Inc. announced today the addition of Dr. William E. Cohn to its board of directors. On March 10, 2011, Dr. Cohn and Dr. Bud Frazier implanted the world's first continuous-flow artificial heart in a human patient, a significant advance that promises a smaller and much more durable alternative to existing artificial hearts.The procedure took place at the Texas Heart Institute, founded by the famous heart surgeon Dr. Denton Cooley in 1962. Dr.Frazier and Dr. Cohn first began...
New device is designed to improve survival rates from heart attack in high-risk heart patients. NEPTUNE, N.J., March 24, 2011 /PRNewswire-USNewswire/ -- Today at Jersey Shore University Medical Center, 66-year-old heart attack survivor Charles Theodora from Ocean Township became the first NY/NJ Metropolitan resident to be implanted with the experimental AngelMed Guardian cardiac monitor and alert system device that could alert him if a heart attack is imminent. "The key to the AngelMed...
